Eli Lilly (LLY) PT Raised to $580 at Credit Suisse
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Eli Lilly & Co. (LLY) upgraded at Jefferies - sees near-term revenue and EPS upside
August 9, 2023 11:00 AM EDTEli Lilly & Co. (NYSE: LLY) was raised to Buy from Hold at Jefferies on Wednesday, with analyst Akash Tewari raising the price target to $615 per share from $430.
The upgrade follows two positive data points for the pharmaceutical company. Tewari explained that "SELECT showed... More
